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Abstract 
Dozens of mutations throughout the 
sequence of the gene encoding superoxide 
dismutase 1 (SOD1) have been linked to toxic 
protein aggregation in the neurodegenerative 
disease amyotrophic lateral sclerosis (ALS). A 
parsimonious explanation for numerous genotypes 
resulting in a common phenotype would be 
mutation-induced perturbation of the folding free-
energy surface that increases the populations of 
high-energy states prone to aggregation. The 
absence of intermediates in the folding of 
monomeric SOD1 suggests that the unfolded 
ensemble is a potential source of aggregation. To 
test this hypothesis, here we dissected SOD1 into a 
set of peptides end-labeled with FRET probes to 
model the local behavior of the corresponding 
sequences in the unfolded ensemble. Using time-
resolved FRET, we observed that the peptide 
corresponding to the loop VII-β8 sequence at the 
SOD1 C-terminus was uniquely sensitive to 
denaturant. Utilizing a two-dimensional form of 
maximum entropy modeling, we demonstrate that 
the sensitivity to denaturant is the surprising result 
of a two-state-like transition from a compact to an 
expanded state. Variations of the peptide sequence 
revealed that the compact state involves a 
nonnative interaction between the disordered N-
terminus and the hydrophobic C-terminus of the 
peptide. This nonnative intramolecular structure 
could serve as a precursor for intermolecular 
association and result in aggregation associated 
with ALS. We propose that this precursor would 
provide a common molecular target for therapeutic 
intervention in the dozens of ALS-linked SOD1 
mutations. 
 
Introduction 
Amyotrophic Lateral Sclerosis (ALS) is a 
neurodegenerative disorder affecting motor neuron 
cells, where it causes progressive loss of muscle 
control and eventual death (1, 2). Patients afflicted 
with ALS often only survive 2-3 years after the 
initial onset of symptoms, demonstrating the rapid 
and invariably fatal effects of the disease. The 
majority of all ALS cases occur in a sporadic 
nature, and only a small fraction (~10%) are linked 
to heritable mutations (1, 2). The first of the 
familial ALS proteins to be discovered was Cu,Zn 
superoxide dismutase (SOD1) (3). SOD1 is a 
homodimeric protein in which each monomer is 
comprised of a 153-residue chain that adopts a β-
sandwich fold. Each monomer is stabilized by an 
intramolecular disulfide bridge and contains two 
metal ion cofactors, zinc and copper (Fig. 1A). 
The zinc ion has been shown to stabilize the 
protein, while the copper ion is crucial to the 
enzymatic activity of SOD1 (4). Intriguingly, >170 
mutations in the sod1 gene linked to ALS are 
located throughout the sequence of the protein 
(http://alsod.iop.kcl.ac.uk/) (5).  
Although the mechanism of pathogenesis 
by mutations in SOD1 is poorly understood, a 
hallmark of ALS and many other 
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neurodegenerative diseases is the observation of 
large protein-rich aggregates in affected tissues 
(6). The observation of a common endpoint of 
large cellular inclusions has given rise to the 
hypothesis that ALS may result from toxicity 
related to protein misfolding and subsequent 
aggregation (7, 8). While the disulfide-intact, 
metal-bound SOD1 dimer is remarkably stable and 
resistant to aggregation (9), mutations are known 
to destabilize the native dimer and increase the 
populations of folded and unfolded forms of the 
monomeric protein that may nucleate aggregation 
(10–14). Several studies have suggested specific 
structures for such misfolded monomers and 
nonnative dimers (15–18). However, the large 
number of ALS-linked SOD1 mutations and, in 
particular, their distribution throughout the 
sequence, motivated us to propose a general 
explanation for the aggregation phenomenon. 
Work from our lab on ALS variants of 
SOD1 have revealed that: (A) the destabilization 
of the metal-free native dimeric state increases the 
populations of both the folded and unfolded forms 
of the monomer (10), (B) the unfolded form of the 
disulfide-reduced monomer is favored at 
physiological temperatures (19), and (C) the 
lifetime of the unfolded monomer, prior to folding, 
is remarkably long, >10 s (20). These observations 
support the hypothesis that the unfolded form of 
SOD1, after synthesis on the ribosome and prior to 
folding and maturation, is the source of 
aggregation in motor neurons. Also supporting this 
hypothesis are the results of Lang et al. (21) which 
showed that the lag time prior to fibrillar 
aggregation of SOD1 in vitro was linked to the 
magnitude of population of SOD1 in the unfolded 
state. Increasing the unfolded state population with 
denaturant led to a decrease in the lag time and 
increase in the fibrillation rate, implicating the 
unfolded state as a common precursor for the 
aggregation of ALS variants. This work was 
expanded upon by comparison of the calculated in 
vitro aggregation rates to the in vivo aggregation 
rates determined for several mouse models (22). 
The good agreement argues for a common 
mechanism of aggregation in vitro and in vivo. 
Eisenberg and colleagues have found that 
two heptapeptides derived from SOD1, one from 
the loop between β6-β7 and the other from β8, are 
capable of forming cross-beta structures that could 
serve as precursors to large scale aggregates (23). 
The concept that discrete segments of SOD1 could 
serve as critical nucleation sites is further 
supported by the results of proteolytic digestion 
experiments on in vitro and in vivo derived 
aggregates of SOD1 (24). Three different 
continuous segments of SOD1, spanning β1-β3 (an 
interlocking pair of β-hairpins), β5-β6 (a β-
hairpin) and Loop VII-β8 (a region that lacks 
native self-contacts) were shown to be strongly 
protected against proteolysis in vitro; in vivo, only 
the Loop VII-β8 segment was protected. 
Building upon these results, we 
investigated the propensity for spontaneous 
collapse in five peptides that span the entire 
sequence of SOD1. We found that only the peptide 
corresponding to the Loop VII-β8 segment of 
SOD1 was capable of adopting a compact 
structure. Surprisingly, the compact form is 
separated from the expanded form by an energy 
barrier that gives rise to an apparent two-state 
behavior when exposed to increasing 
concentrations of denaturant, rather than a gradual 
swelling of the segment as would be expected for 
a randomly collapsed state. We propose that the 
Loop VII-β8 segment as a promising candidate to 
be the primary nucleation site for the aggregation 
of ALS variants of SOD1 in ALS.  
 
Results 
Strategy 
We adopted the time-resolved FRET 
(trFRET) technique to measure the compaction of 
a set of peptides spanning the SOD1 sequence: the 
β1-β3 peptide (residues 1-36), the β4 peptide 
(residues 32-57), the Loop IV peptide (residues 
58-86), the β5-β7 peptide (residues 87-120) and 
the Loop VII-β8 peptide (residues 121-153) (Fig. 
1B and Materials and Methods). Three of these 
peptides were chosen on the basis of their 
resistance to proteolysis in in vitro and in vivo 
aggregates (24), supposing that these segments 
might be capable of nucleating aggregation 
reactions. The remaining two peptides, spanning 
residues 32-57 and 58-86, completed the set 
spanning the entire sequence. The peptides were 
purchased in pairs such that one of the pair 
contained only a single tryptophan (Trp) donor 
residue at or near one terminus, serving as the 
donor-only peptide (DO). The second member of 
the pair contained a tryptophan residue as well as a 
5-((2-aminoethyl)amino)naphthalene-1-sulfonic 
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acid (EDANS) moiety conjugated to a glutamic 
acid residue at the other terminus, serving as the 
donor-acceptor peptide (DA). The Förster distance 
for Trp-EDANS is ~22 Å and is suitable for 
measuring the dimensions of peptides of these 
lengths.  
 
FRET Efficiency from time-resolved 
fluorescence data 
To test the state of compaction for each 
peptide we observed the excited state decay for 
each DO and DA pair as a function of denaturant 
using time-correlated single photon counting as 
previously described (25). We used Maximum 
Entropy Modeling (MEM) (26, 27) to fit these 
decays to rate distributions using the equation: 
𝐼𝐷𝑂/𝐷𝐴(𝑡) = ∫ 𝑝(𝑘𝑑)𝑒
−𝑘𝑑∙𝑡𝑑𝑘𝑑             (Eq. 1) 
where 𝐼𝐷𝑂/𝐷𝐴 is the observed excited state decay 
for the DO or DA peptide, 𝑝(𝑘𝑑)  is the 
distribution of excited-state decay rates, 𝑘𝑑  is the 
donor decay rate constant and is also the inverse of 
the donor lifetime, 1/τ, and 𝑡  is the time. From 
these distributions, we determined the quantum 
yield weighted average lifetime of the Trp,  𝜏𝑄𝑌 , 
using the equation: 
𝜏𝑄𝑌 =  
Σ𝑖𝛼𝑖𝜏𝑖
2
Σ𝑖α𝑖𝜏𝑖
                           (Eq. 2) 
where 𝛼 is the amplitude associated with a distinct 
lifetime, 𝜏 , from the rate distribution. We then 
determined the quantum yield weighted averaged 
trFRET efficiency for each peptide and using the 
equation: 
 𝐸𝑡𝑟𝐹𝑅𝐸𝑇 = 1 −
𝜏𝐷𝐴
𝑄𝑌
𝜏𝐷𝑂
𝑄𝑌                       (Eq. 3) 
 
Denaturant dependence of average trFRET 
efficiency 
The quantum yield weighted average 
trFRET efficiency for the set of five peptides 
spanning the SOD1 sequence is plotted as a 
function of denaturant concentration in Fig. 2A. 
Strikingly, the trFRET efficiencies the Loop IV 
and Loop VII-β8 peptides were dependent on the 
urea concentration; the trFRET efficiencies of the 
remaining peptides were independent of the urea 
concentration. The trFRET efficiencies of both the 
Loop IV and Loop VII-β8 peptides decreased with 
increasing urea concentration. The decrease for the 
Loop VII-β8 peptide was distinctly nonlinear and 
larger than that for the linear decrease for the Loop 
IV peptide. The expansion of the Loop VII-β8 
peptide with denaturant is independent of the 
peptide concentration over the range from 2 to 20 
μM, eliminating peptide-peptide interactions as an 
explanation for its behavior.  
Noting that the β5-β6 segment, residues 
82-102, forms a short β-hairpin in the native 
structure and was also found to be protected from 
proteolysis in in vitro aggregates (24), we 
examined the trFRET response of a peptide 
corresponding to this hairpin to increasingly 
denaturing environments (Fig. S1). This peptide 
was also found to be insensitive to denaturant. 
As an independent test of the formation of 
structure in these peptides, we measured the far-
UV CD spectra of each in the absence and 
presence of denaturant (Fig. S2). With the 
exception of the Loop VII-β8, the spectra in 
aqueous and denaturing conditions are coincident. 
We conclude that none of the other peptides 
formed detectable secondary structure.   
The Loop VII-β8 peptide is unique in that 
the loop segment is of low complexity and polar, 
typical of an intrinsically disordered protein (28), 
while the β8 sequence is almost entirely nonpolar. 
To test the involvement of these distinctly 
different sequences at the termini of this peptide in 
its trFRET efficiency, we examined the behavior 
of two variants. One replaces isoleucine 149 in the 
β8 region with a threonine, an ALS-linked 
mutation that eliminates protection against 
proteolysis for in vitro aggregates of SOD1 (24). 
The other variant truncates five residues, EKADD, 
from the N-terminus (Fig. S3). We found that the 
trFRET efficiency for both variants in water is 
similar to that of the WT peptide in highly 
denaturing conditions (Fig. 2B). The trFRET 
efficiency for the I149T variant is independent of 
denaturant concentration while that of the 
truncated variant experiences a small linear 
decrease, similar to the behavior of the Loop IV 
peptide. Surprisingly, these results show that both 
the polar N- and nonpolar C-termini of the Loop 
VII-β8 peptide are involved in stabilizing the 
compact form of the peptide.  
 
Gradual swelling or discrete unfolding? 
The sensitivity of the trFRET efficiency to 
denaturant for the Loop IV and Loop VII-β8 
peptides could reflect a gradual expansion from a 
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nonspecific collapsed state (29–31) or a two-state-
like expansion from a discrete compact state to an 
expanded unfolded state (32). To resolve this 
issue, we utilized a two-dimensional form of 
Maximum Entropy Modeling (2DMEM)(25). 
2DMEM is unbiased in that it makes no 
assumptions regarding the number of 
subpopulations or their lifetimes and allows for the 
possibility that each could have a distinct distance 
distribution (25). By analyzing our time-resolved 
fluorescence data with MEM, we can distinguish 
states that are resolved on the nanosecond time-
scale. In 2DMEM, the raw excited state decays of 
the DO and DA peptides are globally fit using a 
2D rate distribution matrix of donor decay, kd and 
energy transfer, kET, rate constants using the 
following equations: 
𝐼𝐷𝑂(𝑡) = ∫ 𝑝(𝑘𝑑)𝑒
−𝑘𝑑∙𝑡𝑑𝑘𝑑             (Eq. 1) 
𝐼𝐷𝐴(𝑡) = ∬ 𝑝(𝑘𝑑 , 𝑘𝐸𝑇)𝑒
−(𝑘𝑑+𝑘𝐸𝑇)∙𝑡𝑑𝑘𝑑𝑘𝐸𝑇   (Eq. 5) 
There are two striking features in the 
results of the 2DMEM analysis of the Loop VII-β8 
peptide (Fig. 3A). First there are multiple values of 
kd and kET operative in the excited state decay. The 
three donor decay rate constants at 0.3, 1, and 8 ns-
1 are characteristic of tryptophan (33), but only the 
slower two are FRET competent. The presence of 
both low and high FRET states with kET values of 
<1 and >1 ns-1, respectively, indicate the presence 
of both expanded and compact states of the 
peptide. As the urea concentration increases, the 
population of the compact, high FRET state 
decreases while the population of the expanded, 
low FRET state increases in a concerted manner 
(Fig. 3B-3E). The results show that the change in 
trFRET efficiency for the Loop VII-β8 peptide 
reflects a two-state-like process between compact 
and expanded states separated by a kinetic barrier 
that is long relative to the nanosecond timescale of 
Trp excited-state decay. A denaturant-induced 
expansion of a randomly collapsed peptide would 
have produced a continuous shift of the high 
FRET state to the low FRET state. As a control, 
2DMEM analysis of the β1-β3 peptide data in the 
absence of denaturant reveals only an expanded, 
low FRET state (Fig. 3F). The observation of a 
single donor decay rate constant for this peptide 
suggests that sequence differences in proximity to 
the indole side chain influence the rotamer 
distribution, which is often offered as an 
explanation for the multiple lifetimes for Trp (34, 
35). The β1-β3 peptide is unique among the 
examined peptides as the Trp donor is not at a 
terminus of the peptide, and the presence of 
residues before and after the Trp may give rise to 
the single lifetime distribution. 
We also used 2DMEM analysis to 
examine the behavior of the Loop VII-β8 peptide 
variants in water (Fig. 4A-C). Neither the 
truncated nor the I149T variants were found to 
populate a compact, high FRET state, and both 
had trFRET efficiencies comparable to that for the 
WT Loop VII-β8 peptide under strongly 
denaturing conditions. We conclude that both the 
polar residues in the electrostatic loop and the 
nonpolar residues of β8 are involved in the 
formation of the compact state. The absence of a 
compact state for the truncated variant eliminates 
the possibility that other, intervening segments of 
the Loop VII-β8 peptide are involved in the 
compact state and indicates that the donor-
acceptor probes do not drive the formation of the 
compact state. 
We also used 2DMEM analysis to 
examine the Loop IV peptide in water and found 
that it does not populate a compact, high FRET 
state distinct from the expanded low FRET state 
(Fig. 4D). The continuous intensity from the low 
to high FRET region reflects the breadth of the 
conformational ensemble sampled by this peptide, 
and the small shift in response to increasing 
amounts denaturant (Fig. S4) is evidence that the 
change in trFRET observed in Fig. 2 reflects a 
gradual expansion of the molecule.  
 
Dimensional analysis of the compact state for the 
Loop VII-β8 peptide in water 
 The energy transfer rate constant, kET, axis 
of the 2DMEM distributions (Fig. 3, 4 first panel) 
can be transformed into end-to-end distances 
through the Förster equation (see Materials and 
Methods). The transformation yields a matrix that 
provides the lifetime distribution of the donor 
residue, the end-to-end distance distribution for 
the peptide, as well as information about the donor 
lifetimes present in each ensemble of states. The 
result for the WT Loop VII-β8 peptide in the 
absence of denaturant is shown as a three-
dimensional surface in Fig. 5, and the lifetime 
distribution of the Trp donor and the distance 
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distribution are projected along the XZ and YZ 
axes, respectively.  
 The lifetime distribution contains three 
peaks at ~0.3, ~1, and ~7 nanoseconds, in good 
agreement with typical complex lifetime 
distributions of Trp (33). The distance distribution 
shows a significant fraction of the population is 
compact with an end-to-end distance (REED) of ~14 
Å that is only apparent from the two slower 
lifetimes. The conformational ensemble of the 
expanded state is very broad, with an estimated 
REED >30 Å. For reference, the expected REED for a 
random coil of 35 residues is ~45 Å (36).  
 
Discussion 
The C-terminus of SOD1 forms a compact state 
Our trFRET data show that only the Loop 
VII-β8 peptide from SOD1 is capable of forming a 
compact thermodynamic state in water. The 
concerted transition from a compact to an 
expanded state with urea implies an intervening 
energy barrier; the sensitivity to urea reflects the 
burial of surface area from solvent, and the 
presence of comparable populations of the 
compact and expanded states are consistent with 
marginal stability (∆G0 ≈ 0 kcal/mol). The 
sensitivity of the compact state to the truncation of 
five residues (EKAAD) from the N-terminus and 
the I149T mutation near the C-terminus 
demonstrates their mutual involvement in its 
structure. These same segments are not in contact 
in the native conformation (Fig. 1A), suggesting 
that nonnative interactions are responsible for its 
formation. Interestingly, a peptide spanning 
residues 131-153 of SOD1 was used to develop an 
antibody recognizing misfolded, but not native, 
SOD1, consistent with our interpretation (37, 38).   
 One possibility for the nonnative structure 
is the formation of a β-hairpin by the nonpolar 
residues that form β8 and a pair of glycines at 
positions 27 and 30 that could enable a turn (see 
Experimental Procedures for the sequence). A 
small β-hairpin would explain the far-UV CD 
spectra observed for the Loop VII-β8 peptide in 
water (Fig. S2). This hairpin could serve to 
sequester the hydrophobic side chains from 
solvent and serve as a platform to interact with the 
polar residues at the N-terminus of the peptide.   
 
Prior studies on the folding free energy surface 
of SOD1 
Classic thermodynamic and kinetic studies 
of the folding of the monomeric chain of SOD1 
have concluded that the reaction is well described 
by a two-state process, with a high barrier between 
the native and unfolded states (39). However, 
ensemble measurements may miss complexities 
that could appear in the folding of an individual 
chain. Woodside and colleagues have examined 
the folding free energy surface of a single 
molecule of SOD1 when subjected to a constant 
force exerted on the N- and C-termini (15). They 
found a complex set of partially-unfolded states 
that reflect the progressive unraveling of the β-
sandwich architecture by the loss of individual β-
strands. The initial step was the rupture of the β8 
edge strand, and the final steps involved the 
disruption of structure in the β1-β2-β3 set of 
interlocking β-hairpins in one face of the sandwich 
and β4 in the opposing face. A contrasting view of 
the folding free energy surface of SOD1 in water 
at the individual amino acid level was obtained by 
hydrogen exchange (HDX) NMR spectroscopy 
(40). HDX-NMR is exquisitely sensitive to the 
presence of high-energy, partially-unfolded states 
of the sort predicted by the pulling experiments. 
The HDX-NMR results were consistent with a 
native basin defined by an intact β-sandwich, 
several of whose β-strands frayed at their termini. 
The majority of the main chain amide hydrogens 
in the β-strands exchanged in the unfolded state, 
i.e., not on the native side of the barrier to 
unfolding. There was no evidence for the partially-
folded structures detected by the pulling 
experiment. Consistent with these results are those 
of kinetic folding studies of SOD1 by CD 
spectroscopy that did not detect the formation of 
secondary structure prior to the rate-limiting step 
in folding (20), i.e., on the unfolded side of the 
barrier to the native state. With the exception of 
the C-terminal peptide, the failure to detect 
compaction in peptides modeled after obvious 
elements of substructure in SOD1 in our trFRET 
experiments are in agreement with the HDX-NMR 
and CD studies. In other work, the partially-
unfolded states observed by pulling experiments 
have been found to depend on the location of the 
tethers to exert the pulling force (41, 42). It 
remains to be seen how to relate the energy 
surfaces generated by pulling experiments on a 
single molecule with ensemble measurements 
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using hydrogen exchange or chemical 
denaturation. 
 
A mechanism for the aggregation of SOD1 by the 
Loop VII-β8 segment 
 The >10 s lifetime of the unfolded state of 
SOD1 (39), prior to folding and maturation, would 
promote the formation of the compact structure at 
the C-terminus. A conceptual model for the 
mechanism by which this nonnative structure 
could lead to aggregation is shown in Fig. 6. The 
intrinsically long lifetime of the unfolded state 
combined with its being favored under 
physiological conditions by ALS mutations (19), 
provides an environment in which the 
intramolecular interactions in a single chain are 
replaced by intermolecular interaction between 
pairs of chains. These dimers could then 
progressively add chains to form a collection of 
soluble oligomers. The high local concentration of 
SOD1 chains in these oligomers would enhance 
the subsequent maturation to fibrils or amorphous 
aggregates. The observation that only the C-
terminus is protected against proteolysis in 
aggregates extracted from mouse motor neurons 
suggests that this region is the primary driver of 
aggregation. 
We used the aggregation prediction 
algorithms Aggrescan (43), WALTZ (44), and 
TANGO (45) to examine which of the peptides 
would be predicted to be prone to aggregation 
(Fig. S5). While two peptides, β4 and Loop IV, 
were predicted to have little or no aggregation 
prone stretches, the other peptides, β1-β3 and β5-
β7 and Loop VII-β8, were predicted to have 
several regions that could be prone to aggregation. 
Interestingly, the only peptide where the three 
different algorithms show consensus is the Loop 
VII-β8 peptide and it is also the most hydrophobic 
region of the SOD1 sequence (46). 
 This mechanism does not account for the 
properties of the I149T mutation. I149T disrupts 
the compact structure in the C-terminus and 
eliminates protection against proteolysis for in 
vitro aggregates (24); however, it causes ALS. The 
observation that the β1-β3 and the β5-β6 segments 
are protected against proteolysis for in vitro 
aggregates of I149T shows that secondary 
nucleation sites come into play when the primary 
site is destabilized. Further support for alternative 
nucleation sites is the existence of the ALS-linked 
variants L126X, G127X, G141X, and C146X 
which truncate varying amounts of the C-terminus 
of SOD1 (5). The L126X variant was also shown 
to form in vitro aggregates with protection patterns 
similar to I149T (24). The existence of multiple 
pathways through which SOD1 can aggregate may 
also explain how different ALS-inked mutants 
give rise to morphologically distinct aggregates 
(47). 
Another noteworthy element of the 
mechanism we propose is that it is not dependent 
upon the presence of an ALS-linked SOD1 
mutation. The long lifetime of the unfolded chain, 
>10 sec, would provide an opportunity for the C-
terminal region to sample the nonnative structure 
even in the WT-SOD1 background. The chain 
containing this nonnative structure could then be 
recognized by other misfolded protein partners, 
thereby providing an explanation for the recent 
observation of aggregated WT-SOD1 in tissue 
from patients with pathological ALS mutations in 
other genes (47).  
Implications for therapeutic targets 
 The swap of intramolecular interactions 
for intermolecular interactions between C-terminal 
segments of unfolded SOD1 is the key step in the 
progression of events leading to soluble oligomers 
and macroscopic aggregation (Fig. 6). One 
therapeutic approach would be to screen for small 
molecules that preferentially stabilize the 
intramolecular, compact state and favor productive 
folding to the native dimer. Most ALS variants of 
SOD1 are extremely stable in their fully mature 
dimeric states (48, 49). An alternative approach, 
shown to be effective in non-human primates (50), 
would be to knockdown the expression of SOD1 
with siRNAs and, thereby, slow the bimolecular 
steps crucial to the formation of soluble oligomers 
and aggregates. While not offering a cure for this 
tragic disease, these approaches or others might 
delay the onset and/or slow the progression of 
ALS. 
 
Experimental Procedures 
Peptide Design and Preparation 
 The peptides spanning the SOD1 sequence 
used in the FRET experiments were ordered form 
New England Peptide Inc., where the proper 
molecular weight was checked by mass 
spectrometry and the purity was ensured to be 
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>95% by HPLC. The sequences corresponding to 
the donor-only peptides follow:  
 
β1-β3 peptide: 
TKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIK 
β4 peptide: 
WGSIKGLTEGLHGFHVHEFGDNTAGC 
Loop IV peptide: 
WTSAGPHFNPLSRKHGGPKDEERHVGDLGN 
β5-β7 peptide: 
VTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHW 
Loop VII-β8 peptide: 
EKADDLGKGGNEESTKTGNAGSRLACGVIGIAQW 
I149T peptide: 
EKADDLGKGGNEESTKTGNAGSRLACGVTGIAQW 
 
Truncated peptide: 
LGKGGNEESTKTGNAGSRLACGVTGIAQW 
β5-β6 peptide:  
GDLGNVTADKDGVADVSIEDSW 
 
The donor-acceptor peptides are comprised of the 
same sequences with a Glu-EDANS moiety at the 
terminus opposite the Trp residue.  
 Small amounts (~1-2 mg) of the peptides 
were weighed out and resuspended in our 
experimental buffer: 20 mM 2-[4-(2- 
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid, 
1mM ethylenediaminetetraacetic acid, and 1 mM 
tris(2-carboxyethyl)phosphine at pH=7.2. Each 
peptide stock was filtered through a PES 0.22 μm 
filter and the concentrations were then determined 
using the 280 absorbance peak from the Trp donor 
(ε280=5690 M-1cm-1) using a Cary 100-UV/Vis 
spectrophotometer. For the CD analysis, the same 
method was used, but the buffer used was 10 mM 
Potassium Phosphate, 1mM 
ethylenediaminetetraacetic acid, and 1 mM tris(2-
carboxyethyl)phosphine at pH=7.2. 
 
CD Spectroscopy 
All CD measurements were performed 
with a Jasco-810 spectropolarimeter (Jasco Inc., 
Easton, MD) using a water-cooled Peltier unit. 
The spectra of a monomeric variant of SOD1 and 
the Loop VII-β8 and β1-β3 peptides from 190 to 
260 nm were monitored using a quartz 0.1-cm 
path-length cuvette at a scan rate of 20 nm per min 
and an 8 second response time. The same methods 
were used to collect denatured spectra of the 
peptides, yet from only 215-260 nm to avoid 
scattering.  
 
Time-Resolved FRET Measurements 
The excitation was provided by the tripled 
output of a Ti:sapphire laser at 3.8 MHz repetition 
rate as previously described (25, 32). Excitation 
power was kept at several hundred μWatts at 292 
nm. Counting rates in the detector channel were 
limited to 1×105 counts per second. A 357 nm 40 
nm wide bandpass filter (Semrock, Rochester, 
NY) was used to select the Trp emission. 
The samples were prepared from stocks of 
peptide in buffer and peptide in ≥ 6 M urea and 
mixed precisely using a Hamilton Microlab 500 
titrator and in-house software. Equilibrium 
measurements were performed by interfacing a 
home-built autosampler running custom LabVIEW 
software (available at www.osmanbilsel.net) to the 
lifetime instrument. Each sample in a 96-well 
microplate was brought into a flow cell 
(1mm×1mm) using a Hamilton Microlab 560 dual 
syringe pump and flowed in an oscillating pattern 
at a flow rate of 10 μL/s during data collection. 
Doing so reduced continuous exposure of the 
sample to the beam to <1 sec and minimized 
photobleaching. An N-acetyl tryptophanamide 
(NATA) control was obtained prior to each 
titration in order to obtain relative quantum yields 
for all of the samples.  
 
Maximum Entropy Modeling 
 Kumar et al. (27, 51) have shown that 
MEM can recover the distribution of decay rates 
from time-resolved data. To determine the trFRET 
values as a function of denaturant (Fig. 2A-2B), 
the excited-state decay of the Trp donor in the DO 
and DA peptides at each urea concentration were 
fit using Eq. 1. These distributions were used to 
calculate the quantum-yield weighted averaged 
lifetimes using Eq. 2 from which the trFRET 
efficiencies were calculated using Eq. 3.  
The 2DMEM used to further analyze the 
time-resolved data used Eq. 1 and Eq. 5 to 
simultaneously fit the excited-state decays of the 
DO and DA samples, respectively. The fitting of 
all the MEM data was done with in-house software 
coded in LabVIEW (National Instruments) and 
available at https://osmanbilsel.net/software/. The 
p(kd,kET) distributions were represented by 50×50 
grids of rates in logarithmic rate space. No scaling 
of the DO and DA traces was used in the global 
fitting except in cases where a concentration 
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difference was known to be present. Additional 
terms accounting for scattered light and infinite 
time offsets were included in these analyses, but 
these were negligible and exclusion of these terms 
did not affect the resulting distributions.  
 These distributions were converted into 
efficiency histograms and distance distributions 
using another in-house software package that 
applies a quantum-yield correction to the R0 of the 
donor-acceptor pair. The output of this software 
was then plotted in Fig. 5 as a three-dimensional 
surface of REED, kd, and normalized Amplitude 
using the online open source software plot.ly. 
Two-dimensional projections of the REED vs 
normalized amplitude and kd vs normalized 
amplitude distributions were also plotted along 
their respective axes. 
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FOOTNOTES 
The abbreviations used are: SOD1- Superoxide Dismutase 1, trFRET- time resolved FRET, trp- 
tryptophan, DO- donor-only, EDANS- 5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid, DA- donor-
acceptor, MEM- Maximum Entropy Modeling, 2DMEM- Two-dimensional Maximum Entropy 
Modeling, REED- end-to-end distance, HDX-NMR- Hydrogen exchange NMR, NATA- N-acetyl 
tryptophanamide,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 at U
niversity of M
assachusetts M
edical Center/The Lam
ar Soutter Library on A
ugust 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Non-native structure in the C-terminus of SOD1 
 13 
Figure 1. SOD1 Structure and Peptide Design. A, The ribbon diagram of Cu,Zn SOD1, adapted from 
PDB: 2C9V, is shown. The bound copper and zinc metal cofactors are shown as orange and grey spheres, 
and the internal disulfide bond is shown in yellow. The zinc binding and electrostatic loops are shown in 
green and red, respectively. B, Each of the examined peptides of SOD1 is mapped onto the topology 
diagram with a unique color in the top left. A sketch demonstrating how the FRET donors and acceptors 
were placed onto the termini of one of the peptides is shown on the top right. The exact residue length of 
each peptide is shown along a linear map of the SOD1 structure using the same colors as in the topology 
map above. The colors associated with each peptide are carried forward to Figure 2.  
 at U
niversity of M
assachusetts M
edical Center/The Lam
ar Soutter Library on A
ugust 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Non-native structure in the C-terminus of SOD1 
 14 
 
 
Figure 2: trFRET efficiency of SOD1 peptides as a function of denaturant. A, The quantum yield 
weighted average trFRET efficiencies for each of the five SOD1 peptides are shown as a function of 
denaturant (colors as in Figure 1B), and trend lines are shown to demonstrate the linearity or nonlinearity 
of the FRET change for each peptide. B, The FRET efficiencies for the Loop VII-β8 peptide (red) and the 
I149T (maroon) and truncated (pink) variants are shown as a function of denaturant and trend lines are 
shown to demonstrate the linearity or nonlinearity of the FRET change for each peptide. The data points 
represent the average of ≥3 separate experimental runs, and the error bars are the standard deviation 
thereof.   
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Figure 3. 2DMEM distributions for the Loop VII-β8 peptide as a function of denaturant. A-E, The 
concentrations of urea examined are shown in the lower right corners of each panel, and the upper right 
corner of each panel is labeled with the examined peptide. The amplitude of the distributions in B-E was 
normalized to the amplitude in A to emphasize the change in response to denaturant. F, The 2DMEM 
distribution for the β1-β3 peptide in the absence of denaturant is shown for reference. The diagonal white 
reference lines are marked with the FRET efficiency along each line. The yellow arrows indicate the 
amplitude associated with extended conformations, and the cyan arrows indicate the amplitude associated 
with compact conformations.  
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Figure 4. The 2DMEM distributions for the Loop VII-β8 peptide variants. The concentrations of urea 
examined are shown in the lower right corners of each panel, and the upper right corner of each panel is 
labeled with the examined peptide. The diagonal white reference lines are marked with the FRET 
efficiency along each line. The yellow arrows indicate the amplitude associated with extended 
conformations, and the cyan arrows indicate the amplitude associated with compact conformations.  
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Figure 5. Three-dimensional surface of the transformed 2DMEM distribution for the WT Loop 
VII-β8 peptide in the absence of denaturant. The two-dimensional Trp lifetime distribution and the 
end-to-end distance distribution are shown as projections along the XZ and YZ axes, respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 at U
niversity of M
assachusetts M
edical Center/The Lam
ar Soutter Library on A
ugust 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Non-native structure in the C-terminus of SOD1 
 18 
  
 
Figure 6. A model for the role of the compact Loop VII-β8 region in ALS-linked SOD1 aggregation. 
In this model, the C-terminal region (black line) is able to form the compact state, while the rest of the 
polypeptide chain remains unfolded (red dotted line). Once the compact state has formed, it can meet 
other compact states and form lower order, soluble oligomers. These oligomers could then further recruit 
polypeptide chains until insoluble aggregates, either fibril-like or amorphous, are formed. 
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